SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 24, 2026

EVMN

Evommune, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $202K total
Actionable Insight • Neutral

The insider sales are too small to signal a change in business outlook. Monitor upcoming clinical catalysts or earnings for material developments. The stock's strong analyst consensus (94% bullish) and institutional accumulation (4 funds doubled positions in Q1) suggest the insider activity is not a red flag.

DirectionNeutral
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
EVMN ▼ -60.01% at T+60d
NEUTRAL call -60.01% · α vs SPY -63.74% · entry $24.13 → $9.65
Entry = T+0 close
Jun 24, 2026
via day close
T+1d
+4.35%
call +4.35% · α +5.07%
$25.18
settled 4mo ago
T+5d
-46.87%
call -46.87% · α -48.43%
$12.82
settled 4mo ago
T+20d
-53.09%
call -53.09% · α -53.62%
$11.32
settled 3mo ago
T+60d
-60.01%
call -60.01% · α -63.74%
$9.65
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Evommune (CEO and CSO) sold a combined $202K in open-market sales on June 22, 2026. The total represents less than 0.03% of the $873M market cap, making the cluster trivial in size. Additional insider sales by the Chief of Dev. Operations on the same day bring the cluster total to ~$655K, still under 0.1% of market cap. The sales are likely routine portfolio adjustments and carry no material bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$202.0K
Insiders
2

Key Facts

  • CEO Luis C. Pena sold 7,438 shares for $169K at $22.71.
  • CSO Jeegar Pravinkumar Patel sold 1,488 shares for $33K at $22.50.
  • Total open-market sales in the cluster: $202K (0.023% of market cap).
  • Including a separate sale by the Chief of Dev. Operations, the broader cluster totals ~$655K (0.075% of market cap).
  • All sales occurred on June 22, 2026, the last day of the 7-day cluster window.

Financial Impact

Insider sales of $202K–$655K are immaterial relative to $873M market cap.

dilution

Risk Factors

  • Insider sales could accelerate if the stock continues to rally, but current levels are routine.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EVMN-1782345651578
15 reports for EVMN
Performance horizon
75% Hit rate @ T+60 3 of 4 directional calls Went positive at some point 3 of 5 best @ T+60▲ +41.15%May 28, 2026
Filters
Rows
Reports for EVMN — sortable, filterable
TypeNow
Oct 1, 2026
26d ago
8-K
BULLISH ★ 7/10
$7.21awaiting T+60—$5.16 (−28.43%)
Sep 15, 2026
6w ago
8-K
NEUTRAL ★ 4/10
$9.99awaiting T+60—$5.16 (−48.35%)
Jul 30, 2026
12w ago
8-K
NEUTRAL ★ 5/10
$11.35 $5.10▼ −55.07%▼ −57.53%$5.16 (−54.54%)
Jul 10, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$12.10 $6.61▼ −45.37%▼ −49.37%$5.16 (−57.36%)
Jun 29, 2026
17w ago
8-K
BEARISH ★ 7/10
$15.05 $9.60▲ +36.21%▲ +40.60%$5.16 (+65.71%)
Jun 24, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.13 $9.65▼ −60.01%▼ −63.74%$5.16 (−78.62%)
Jun 3, 2026
20w ago
Insider Cluster
BEARISH ★ 5/10
$20.69 $13.23▲ +36.06%▲ +37.94%$5.16 (+75.06%)
Jun 2, 2026
21w ago
144
NEUTRAL ★ 3/10
$19.73 $13.48▼ −31.68%▼ −34.18%$5.16 (−73.85%)
Jun 1, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.82 $14.11▼ −28.81%▼ −29.93%$5.16 (−73.97%)
May 28, 2026
21w ago
144
BEARISH ★ 5/10
$23.23 $13.67▲ +41.15%▲ +42.34%$5.16 (+77.79%)
Showing 10 of 15

US Market Status

Market Closed — Opens in 9h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 24, 2026